A detailed history of Smartleaf Asset Management LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 609 shares of ADPT stock, worth $3,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares
609
Previous 572 6.47%
Holding current value
$3,459
Previous $1.98 Million 53.87%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.37 - $5.12 $124 - $189
37 Added 6.47%
609 $3.05 Million
Q2 2024

Aug 13, 2024

BUY
$2.34 - $3.96 $1,338 - $2,265
572 New
572 $1.98 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $812M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.